Mark Abramovitz
Impact in
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Receptor Mechanisms and Signaling 17
- Glutathione Transferases and Polymorphisms 10
- Genomics, phytochemicals, and oxidative stress 10
- Pharmacology 14
- Inflammatory mediators and NSAID effects 14
- Co-authors
- Kathleen M. Metters (14 shared papers)Irving Listowsky (10 shared papers)Yves Boie (9 shared papers)Deborah Slipetz (6 shared papers)Nicole Sawyer (9 shared papers)Brian Leyland‐Jones (16 shared papers)Ryszard Grygorczyk (5 shared papers)Thomas H. Rushmore (3 shared papers)
- Journals
- Journal of Biological Chemistry (9 papers)Molecular Pharmacology (4 papers)Analytical Biochemistry (3 papers)Science (3 papers)Journal of Neurochemistry (3 papers)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Mark Abramovitz
72 papers receiving 5.4k citations
Peers
Comparison fields: 5 of 128
- Pharmacology 1.6k
- Biochemistry 677
- Molecular Biology 2.7k
- Cancer Research 520
- Physiology 866
Countries citing papers authored by Mark Abramovitz
This map shows the geographic impact of Mark Abramovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Abramovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Abramovitz more than expected).
Fields of papers citing papers by Mark Abramovitz
This network shows the impact of papers produced by Mark Abramovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Abramovitz. The network helps show where Mark Abramovitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Abramovitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 473 | |
| 2 | 1994 | 333 | |
| 3 | 1995 | 286 | |
| 4 | 1993 | 265 | |
| 5 | 1997 | 259 | |
| 6 | 1988 | 239 | |
| 7 | 2013 | 215 | |
| 8 | 1998 | 207 | |
| 9 | 1993 | 179 | |
| 10 | 1956 | 178 | |
| 11 | 1993 | 173 | |
| 12 | 1994 | 168 | |
| 13 | 1994 | 149 | |
| 14 | 2009 | 146 | |
| 15 | 1994 | 99 | |
| 16 | 1990 | 94 | |
| 17 | 1988 | 92 | |
| 18 | 2008 | 92 | |
| 19 | 2000 | 91 | |
| 20 | 1989 | 90 |
About Mark Abramovitz
Mark Abramovitz is a scholar working on Molecular Biology, Pharmacology, Genetics, Physiology and Oncology, having authored 73 papers that have together received 5.5k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (17 papers), Inflammatory mediators and NSAID effects (14 papers), Glutathione Transferases and Polymorphisms (10 papers), Genomics, phytochemicals, and oxidative stress (10 papers), Asthma and respiratory diseases (9 papers), Estrogen and related hormone effects (9 papers), HER2/EGFR in Cancer Research (6 papers) and Neuropeptides and Animal Physiology (6 papers). The work is most often cited by research in Pharmacology (1.6k citations), Biochemistry (677 citations), Molecular Biology (2.7k citations), Cancer Research (520 citations) and Physiology (866 citations). Mark Abramovitz has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Kathleen M. Metters, Irving Listowsky, Yves Boie, Deborah Slipetz, Nicole Sawyer, Brian Leyland‐Jones, Ryszard Grygorczyk, Thomas H. Rushmore, Hisato Homma and Seishi Ishigaki. Their work appears in journals such as Journal of Biological Chemistry, Molecular Pharmacology, Analytical Biochemistry, Science and Journal of Neurochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.